Kiniksa Pharmaceuticals International, plc (KNSA)
NASDAQ: KNSA · Real-Time Price · USD
48.24
+0.47 (0.98%)
Feb 23, 2026, 11:00 AM EST - Market open
KNSA Employees
Kiniksa Pharmaceuticals International, had 315 employees as of December 31, 2024. The number of employees increased by 18 or 6.06% compared to the previous year.
Employees
315
Change (1Y)
18
Growth (1Y)
6.06%
Revenue / Employee
$1,898,327
Profits / Employee
$114,025
Market Cap
3.66B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 315 | 18 | 6.06% | 315 | 0 |
| Dec 31, 2023 | 297 | 77 | 35.00% | 297 | 0 |
| Dec 31, 2022 | 220 | 5 | 2.33% | 220 | 0 |
| Dec 31, 2021 | 215 | 47 | 27.98% | 215 | 0 |
| Dec 31, 2020 | 168 | 31 | 22.63% | 168 | 0 |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Bausch Health Companies | 20,700 |
| Perrigo Company | 8,379 |
| Amneal Pharmaceuticals | 8,300 |
| Phibro Animal Health | 2,475 |
| Alkermes | 1,800 |
| HUTCHMED (China) | 1,780 |
| Hims & Hers Health | 1,637 |
| Lantheus Holdings | 808 |
KNSA News
- 3 days ago - Kiniksa Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026 - GlobeNewsWire
- 4 weeks ago - Kiniksa: Arcalyst Is The Engine, But KPL-387 Is The Accelerator - Seeking Alpha
- 5 weeks ago - Kiniksa Pharmaceuticals International, plc (KNSA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 6 weeks ago - Kiniksa Pharmaceuticals Provides Corporate Update - GlobeNewsWire
- 6 weeks ago - Kiniksa Pharmaceuticals to Present at 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 3 months ago - Kiniksa Pharmaceuticals to Present at Jefferies Global Healthcare Conference in London - GlobeNewsWire
- 4 months ago - Kiniksa: How Category Ownership And Higher Duration Are Translating Into Operating Leverage - Seeking Alpha
- 4 months ago - Kiniksa Pharmaceuticals International, plc (KNSA) Q3 2025 Earnings Call Transcript - Seeking Alpha